Bio-Rad Laboratories (NY: BIO )

263.97 -9.14 (-3.35%)

Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2024 Add to My Watchlist

Price and Volume

Volume	300,985
Open	273.68
Bid (Size)	110.00 (1)
Ask (Size)	279.00 (1)
Prev. Close	273.11
Today's Range	263.39 - 276.23
52wk Range	261.59 - 431.79
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months

June 30, 2024

The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory.

Via Benzinga

OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics

June 05, 2024

Via AB Newswire

Performance

YTD	-19.52%	-19.52%
1 Month	-8.65%	-8.65%
3 Month	-22.13%	-22.13%
6 Month	-19.52%	-19.52%
1 Year	-30.09%	-30.09%

More News

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

June 05, 2024

Via TheNewswire.com

The Analyst Landscape: 4 Takes On Bio-Rad Laboratories

May 08, 2024

Via Benzinga

Bio-Rad Laboratories: Q4 Earnings Insights

February 15, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024

February 15, 2024

Via Benzinga

Preview: Bio-Rad Laboratories's Earnings

February 14, 2024

Via Benzinga

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

May 30, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

May 23, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024

May 07, 2024

Via InvestorPlace

Bio-Rad Reports First-Quarter 2024 Financial Results

May 07, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

May 01, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Announces Life Science Group Management Changes

April 26, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?

April 18, 2024

Via Benzinga

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

April 18, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad’s Chief Operating Officer Andrew Last to Retire

April 10, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer

March 20, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day

February 22, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?

February 16, 2024

Via Benzinga

Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday

February 16, 2024

Via Benzinga

Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results

February 15, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024

January 24, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?

January 23, 2024

Via Benzinga

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference

January 02, 2024

From Bio-Rad Laboratories, Inc.

Via Business Wire

S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets

December 07, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.